We've made it to the 1st full week of 2020! In episode 16, we talk about new indications for Fiasp & Keytruda as well as threats by the FDA to generic drug manufacturers. We also talk about HR5534, a new bill introduced into legislation that would expand access to transplant medications for medicare recipients. Don't forget to share this with anyone who wants to get regular updates on new products coming to market! Enjoy!